GO:0046540 U4/U6 x U5 tri-snRNP complex: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0046540 defines the U4/U6 x U5 tri-snRNP complex, a ribonucleoprotein formed by association of the U4/U6 and U5 snRNPs.
• The tri-snRNP is a pre-assembled splicing factor that is recruited to prespliceosomes to form mature spliceosomes.
• Its protein components include Prp31p, Prp3, Prp28, Brr2, and Dim2/TXNL4B, which support stability, activation, and structural integrity.
• Structural studies using NMR-SAXS/WAXS and crystallography have revealed key RNA and protein architectures of the U4/U6 di-snRNA and associated helicases.
• The tri-snRNP is essential for spliceosome activation and catalytic step execution, making it a target for understanding splicing-related diseases.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable functional dissection of tri-snRNP components in human cells.
Description
The U4/U6 x U5 tri-snRNP complex (GO:0046540) is a cellular component defined as a ribonucleoprotein complex formed by the association of the U4/U6 and U5 small nuclear ribonucleoproteins (snRNPs). This tri-snRNP is a key intermediate in the spliceosome assembly pathway, serving as a pre-formed module that is recruited to prespliceosomes to generate catalytically active spliceosomes. Understanding its composition and assembly is fundamental to RNA processing research because it bridges the initial recognition of splice sites with the catalytic steps of pre-mRNA splicing. The complex has been studied extensively in Saccharomyces cerevisiae and human systems, with genetic and biochemical approaches identifying essential proteins such as Prp31p, Prp3, Prp28, and Brr2. Structural analyses, including NMR-SAXS/WAXS of the U4/U6 di-snRNA and crystal structures of human Dim2/TXNL4B and Prp28, have provided mechanistic insights into how this complex maintains stability and guides spliceosome activation. For researchers, the tri-snRNP represents a focal point for investigating splicing fidelity, RNA helicase function, and the molecular basis of diseases linked to splicing dysregulation.
U4/U6 x U5 tri-snRNP complex At A Glance
| GO ID | GO:0046540 |
|---|---|
| GO term | U4/U6 x U5 tri-snRNP complex |
| Ontology | cellular_component |
| Synonym | U4/U6.U5 snRNP complex |
| Major function | Pre-assembled splicing factor that associates with prespliceosomes to form spliceosomes |
| Key protein components | Prp31p, Prp3, Prp28, Brr2, Dim2/TXNL4B |
| Associated RNAs | U4, U6, and U5 small nuclear RNAs |
| Structural methods | NMR-SAXS/WAXS, X-ray crystallography, cryo-EM |
| Model organisms | Saccharomyces cerevisiae, human cell lines |
What Is GO:0046540?
The U4/U6 x U5 tri-snRNP complex is a ribonucleoprotein particle that consists of the U4/U6 di-snRNP and the U5 snRNP associated together. It is a discrete cellular component that functions as a unit during spliceosome assembly, specifically by joining prespliceosomes to form the mature spliceosome. This definition is based on the Gene Ontology annotation GO:0046540, which places the complex in the cellular_component ontology.
Why Is U4/U6 x U5 tri-snRNP complex Important in Cell Biology?
The U4/U6 x U5 tri-snRNP complex is essential for pre-mRNA splicing because it delivers the U4/U6 and U5 snRNPs to the prespliceosome, enabling the formation of the catalytically active spliceosome. Without proper tri-snRNP assembly or recruitment, splicing cannot proceed, leading to widespread defects in gene expression. Mutations or dysregulation of tri-snRNP components have been linked to splicing-related diseases, including cancer and neurodegeneration, making this complex a critical subject for both basic and translational research.
• Central to spliceosome assembly and activation, directly impacting pre-mRNA splicing efficiency.
• Contains multiple essential proteins whose mutations can cause splicing defects.
• Serves as a model for studying RNA-protein and RNA-RNA interactions using structural biology.
• Its assembly is regulated by ATP-dependent helicases such as Brr2, which are critical for spliceosome activation.
• Dysregulation of tri-snRNP components is associated with human diseases including cancer and retinal degeneration.
• Provides targets for CRISPR-based functional genomics and therapeutic intervention.
• Structural insights from the tri-snRNP inform drug discovery for splicing-modulating compounds.
• Understanding its composition aids in interpreting transcriptomic changes in disease models.
What Happens During U4/U6 x U5 tri-snRNP complex?
Assembly of the tri-snRNP from U4/U6 and U5 snRNPs
In simple terms: The U4/U6 and U5 snRNPs come together to form a single larger machine.
The U4/U6 x U5 tri-snRNP complex is formed by the association of the U4/U6 di-snRNP with the U5 snRNP. This pre-assembly allows the tri-snRNP to exist as a discrete particle before engaging with the spliceosome. In Saccharomyces cerevisiae, Prp31p promotes the association of the U4/U6 x U5 tri-snRNP with prespliceosomes, indicating that tri-snRNP formation is a prerequisite for its recruitment function. Structural analysis of the U4/U6 di-snRNA by NMR-SAXS/WAXS has provided insights into the multi-helical RNA architecture that supports this assembly.
Recruitment to prespliceosomes and spliceosome formation
In simple terms: The tri-snRNP docks onto an earlier splicing complex to build the full spliceosome.
Once formed, the tri-snRNP associates with prespliceosomes to generate mature spliceosomes. This step is promoted by Prp31p in yeast, which facilitates the integration of the tri-snRNP into the assembling spliceosome. The recruitment is a critical checkpoint because it commits the spliceosome to the catalytic phase of splicing. The three-dimensional structure of a pre-catalytic human spliceosomal complex B has been determined, revealing the overall architecture of the spliceosome before catalysis, which includes the tri-snRNP components.
Activation by RNA helicases
In simple terms: Molecular motors unwind RNA to switch the spliceosome on.
Spliceosome activation requires ATP-dependent RNA helicases, notably Brr2, which is a component of the tri-snRNP. The large N-terminal region of Brr2 guides productive spliceosome activation by coordinating RNA unwinding. Another helicase, Prp28, is a DEAD-box protein whose structural and functional analysis has shed light on its role in splicing. These helicases are essential for rearranging RNA-RNA and RNA-protein interactions during the transition from the pre-catalytic to the catalytically active spliceosome.
Stabilization by protein components
In simple terms: Proteins hold the complex together and keep it stable.
The stability of the tri-snRNP depends on proteins such as Prp3, which contains a composite double-/single-stranded RNA-binding region that supports tri-snRNP stability and splicing. Prp31p also contributes to the association of the tri-snRNP with prespliceosomes. Additionally, the human protein Dim2/TXNL4B has been structurally characterized at high resolution, and its presence in the tri-snRNP suggests a role in maintaining complex integrity. These proteins ensure that the tri-snRNP remains functional during the dynamic rearrangements of splicing.
Key Genes Involved in GO:0046540 U4/U6 x U5 tri-snRNP complex
The following genes and proteins are core components or regulators of the U4/U6 x U5 tri-snRNP complex, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PRP31 | Promotes association of tri-snRNP with prespliceosomes | Yeast model for spliceosome assembly; human homolog linked to retinitis pigmentosa |
| PRP3 | RNA-binding protein supporting tri-snRNP stability | Mutations cause retinitis pigmentosa; target for splicing studies |
| BRR2 | ATP-dependent RNA helicase guiding spliceosome activation | Key regulator of catalytic activation; structural and functional studies |
| PRP28 | DEAD-box helicase involved in spliceosome rearrangement | Structural analysis reveals mechanism of RNA unwinding |
| DIM2/TXNL4B | Component of tri-snRNP with high-resolution crystal structure | Potential role in complex stability; structural biology target |
| PRP4 | U4/U6 snRNP protein | Component of tri-snRNP; studied in yeast and human |
| PRP6 | U4/U6-U5 tri-snRNP bridging protein | Essential for tri-snRNP formation |
| PRP8 | Core U5 snRNP protein | Central to spliceosome active site |
| SNRNP200 | Human Brr2 homolog | RNA helicase essential for splicing |
| PRPF31 | Human Prp31 homolog | Retinitis pigmentosa-associated gene |
| PRPF3 | Human Prp3 homolog | Retinitis pigmentosa-associated gene |
| PRPF4 | Human Prp4 homolog | U4/U6 snRNP component |
| PRPF6 | Human Prp6 homolog | Tri-snRNP assembly factor |
| PRPF8 | Human Prp8 homolog | Core spliceosomal protein |
| TXNL4B | Human Dim2 homolog | Tri-snRNP component with crystal structure |
| SNRPB | U5 snRNP protein | Component of tri-snRNP |
| SNRPD1 | Core snRNP protein | Stabilizes snRNP complexes |
| SNRPD2 | Core snRNP protein | Stabilizes snRNP complexes |
How Is U4/U6 x U5 tri-snRNP complex Regulated?
The assembly and function of the U4/U6 x U5 tri-snRNP complex are regulated by ATP-dependent RNA helicases such as Brr2, which guides productive spliceosome activation. Prp31p promotes the association of the tri-snRNP with prespliceosomes, acting as a regulatory factor for spliceosome assembly. Additionally, the stability of the tri-snRNP is supported by RNA-binding proteins like Prp3, which contains a composite double-/single-stranded RNA-binding region essential for tri-snRNP stability and splicing. These regulatory mechanisms ensure that the tri-snRNP is correctly assembled and recruited only when needed, preventing aberrant splicing.
U4/U6 x U5 tri-snRNP complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PRPF31 | Retinitis pigmentosa | Knockout or point-mutation in human retinal cells |
| PRPF3 | Retinitis pigmentosa | Knock-in of patient mutations in iPSC-derived photoreceptors |
| BRR2 | Cancer, splicing dysregulation | Overexpression or knockout in cancer cell lines |
| PRP28 | Splicing defects | Point mutation in human cell lines |
| DIM2/TXNL4B | Tri-snRNP stability | Knockout in HEK293 cells |
Retinitis pigmentosa and splicing factor mutations
Mutations in tri-snRNP components, particularly PRPF31 (Prp31p homolog) and PRPF3 (Prp3 homolog), are associated with retinitis pigmentosa, a degenerative retinal disease. Prp31p promotes the association of the U4/U6 x U5 tri-snRNP with prespliceosomes, and defects in this process can lead to splicing abnormalities that affect photoreceptor survival. Prp3 supports tri-snRNP stability, and its dysfunction is linked to retinal degeneration.
Cancer and spliceosome dysregulation
Dysregulation of spliceosome components, including tri-snRNP proteins, has been implicated in cancer. Brr2, an RNA helicase essential for spliceosome activation, is a potential target because its altered activity can affect splicing of genes involved in cell proliferation and survival. Structural and functional studies of Brr2 and Prp28 provide a basis for understanding how mutations in these helicases might contribute to cancer.
Neurodegeneration and splicing defects
Splicing defects caused by mutations in tri-snRNP components can lead to neurodegeneration. The precise assembly of the tri-snRNP is critical for neuronal function, and disruptions in Prp31p or Prp3 have been linked to cellular stress and degeneration. Understanding these mechanisms may inform therapeutic strategies for neurodegenerative diseases.
From U4/U6 x U5 tri-snRNP complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of PRPF31 affect tri-snRNP assembly? | CRISPR knockout in HEK293 or retinal cells |
| How do point mutations in PRPF3 alter splicing? | Knock-in of patient mutations in iPSCs |
| What is the role of BRR2 helicase in activation? | Point mutation or knockout in yeast and human cells |
| Can overexpression of Prp31 rescue splicing defects? | Overexpression in mutant cell lines |
| Where does the tri-snRNP localize in cells? | Tagged knock-in with fluorescent protein |
| What proteins interact with Dim2/TXNL4B? | Affinity purification and proteomics from knockout cells |
How to Study the U4/U6 x U5 tri-snRNP complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| NMR-SAXS/WAXS | RNA structure in solution | U4/U6 di-snRNA architecture |
| X-ray crystallography | Atomic structure of proteins | Dim2/TXNL4B, Prp28 |
| Cryo-EM | 3D structure of large complexes | Pre-catalytic spliceosomal complex B |
| RNA-seq | Global splicing changes | Knockout or mutant cell lines |
| Affinity purification-MS | Protein interactions | Tri-snRNP composition |
| Splicing reporter assays | Splice site usage | Functional validation of mutations |
| CRISPR knockout | Gene function loss | Causal gene testing |
| CRISPR knock-in | Mutant protein expression | Disease modeling |
Structural biology (NMR-SAXS/WAXS, crystallography, cryo-EM)
Structural methods such as NMR-SAXS/WAXS have been used to analyze the multi-helical RNA of the U4/U6 di-snRNA. X-ray crystallography has provided high-resolution structures of human Dim2/TXNL4B and Prp28, revealing atomic details of tri-snRNP components. Cryo-EM has been used to determine the three-dimensional structure of a pre-catalytic human spliceosomal complex B, which includes the tri-snRNP.
RNA-seq and splicing assays
RNA-seq can measure global changes in pre-mRNA splicing upon perturbation of tri-snRNP components. Splicing assays using reporter minigenes can specifically test the impact of mutations in Prp31p or Prp3 on splice site selection.
Proteomics and affinity purification
Affinity purification coupled with mass spectrometry can identify protein-protein interactions within the tri-snRNP complex. This approach helps define the composition and dynamic changes of the complex during spliceosome assembly.
CRISPR-based functional genomics
CRISPR knockout, point mutation, and knock-in models enable causal testing of tri-snRNP genes in human cells. Overexpression models can assess gain-of-function effects and rescue experiments.
How CRISPR Can Be Used to Study GO:0046540 U4/U6 x U5 tri-snRNP complex
Knockout
CRISPR knockout of tri-snRNP genes such as PRPF31 or PRPF3 can reveal their essential roles in splicing and cell viability. Knockout models are useful for assessing loss-of-function phenotypes and identifying compensatory pathways.
Point Mutation
Point mutations in tri-snRNP components, such as those found in retinitis pigmentosa patients, can be introduced using CRISPR base editing or homology-directed repair. These models help dissect the specific effects of disease-associated alleles on tri-snRNP assembly and function.
Knock-in
Knock-in of tagged versions of tri-snRNP proteins, such as fluorescently labeled Prp31p or Dim2, allows live-cell imaging and localization studies. Knock-in of patient mutations enables disease modeling in relevant cell types.
Overexpression
Overexpression of tri-snRNP components like Prp31p can test gain-of-function effects and rescue of splicing defects. This approach is valuable for studying dosage sensitivity and interactions with other spliceosomal factors.
How EDITGENE Supports U4/U6 x U5 tri-snRNP complex Research
Researchers studying U4/U6 x U5 tri-snRNP complex-related genes often need to determine whether a candidate gene is causally involved in splicing regulation or disease. EDITGENE provides comprehensive CRISPR-based services to generate knockout, point-mutation, knock-in, and overexpression cell models, as well as CRISPR library screening and bioinformatics support, enabling rigorous functional interrogation of tri-snRNP components.
Contact EDITGENE today to design your custom CRISPR model for U4/U6 x U5 tri-snRNP complex research.
Frequently Asked Questions About U4/U6 x U5 tri-snRNP complex
What is the U4/U6 x U5 tri-snRNP complex?
It is a ribonucleoprotein complex formed by the association of the U4/U6 and U5 snRNPs, defined by GO:0046540.
What genes are involved in the U4/U6 x U5 tri-snRNP complex?
Key genes include PRP31, PRP3, BRR2, PRP28, and DIM2/TXNL4B, among others.
What is the function of the U4/U6 x U5 tri-snRNP complex?
It promotes the association of the tri-snRNP with prespliceosomes to form spliceosomes, enabling pre-mRNA splicing.
How is the U4/U6 x U5 tri-snRNP complex assembled?
It is formed by the association of the U4/U6 di-snRNP and U5 snRNP, and its recruitment is promoted by Prp31p.
What diseases are linked to tri-snRNP mutations?
Mutations in PRPF31 and PRPF3 are linked to retinitis pigmentosa, and dysregulation of BRR2 is implicated in cancer.
What methods are used to study the tri-snRNP complex?
Structural biology (NMR-SAXS/WAXS, crystallography, cryo-EM), RNA-seq, proteomics, and CRISPR screens are commonly used.
What is the role of Brr2 in the tri-snRNP?
Brr2 is an ATP-dependent RNA helicase that guides productive spliceosome activation.
How does Prp3 support tri-snRNP stability?
Prp3 contains a composite double-/single-stranded RNA-binding region that supports tri-snRNP stability and splicing.
Can CRISPR be used to study tri-snRNP genes?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable functional studies of tri-snRNP components.
What is the GO ID for the U4/U6 x U5 tri-snRNP complex?
The GO ID is GO:0046540.
Conclusion
The U4/U6 x U5 tri-snRNP complex (GO:0046540) is a central component of the spliceosome assembly pathway, formed by the association of U4/U6 and U5 snRNPs. Its protein components, including Prp31p, Prp3, Brr2, Prp28, and Dim2/TXNL4B, are essential for stability, activation, and recruitment to prespliceosomes. Structural and functional studies have provided mechanistic insights into its role in splicing, and mutations in its components are linked to human diseases such as retinitis pigmentosa and cancer. Continued research using CRISPR-based models and advanced structural techniques will further elucidate its function and therapeutic potential.
References
- 1. Weidenhammer EM et al.. 1997. Prp31p promotes the association of the U4/U6 x U5 tri-snRNP with prespliceosomes to form spliceosomes in Saccharomyces cerevisiae.. Mol Cell Biol 17(7):3580-8 PMID: 9199293
- 2. Cornilescu G et al.. 2016. Structural Analysis of Multi-Helical RNAs by NMR-SAXS/WAXS: Application to the U4/U6 di-snRNA.. J Mol Biol 428(5 Pt A):777-789 PMID: 26655855
- 3. Absmeier E et al.. 2015. The large N-terminal region of the Brr2 RNA helicase guides productive spliceosome activation.. Genes Dev 29(24):2576-87 PMID: 26637280
- 4. Jin T et al.. 2013. High-resolution crystal structure of human Dim2/TXNL4B.. Acta Crystallogr Sect F Struct Biol Cryst Commun 69(Pt 3):223-7 PMID: 23519793
- 5. Liu S et al.. 2015. A composite double-/single-stranded RNA-binding region in protein Prp3 supports tri-snRNP stability and splicing.. Elife 4:e07320 PMID: 26161500
- 6. Boehringer D et al.. 2004. Three-dimensional structure of a pre-catalytic human spliceosomal complex B.. Nat Struct Mol Biol 11(5):463-8 PMID: 15098019
- 7. Tauchert MJ et al.. 2016. Structural analysis of the spliceosomal RNA helicase Prp28 from the thermophilic eukaryote Chaetomium thermophilum.. Acta Crystallogr F Struct Biol Commun 72(Pt 5):409-16 PMID: 27139834
- 8. Möhlmann S et al.. 2014. Structural and functional analysis of the human spliceosomal DEAD-box helicase Prp28.. Acta Crystallogr D Biol Crystallogr 70(Pt 6):1622-30 PMID: 24914973
